Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Contract Win

1 Oct 2007 07:02

Sopheon PLC01 October 2007 Embargoed Release: 07:00hrs Monday 1 October 2007 Sopheon Plc ("Sopheon", the "Group" or the "Company") Scott Bader Sharpens Innovation Focus with Sopheon's Accolade(R) System Sopheon, the international software and services company, announced today thatScott Bader, a U.K.-based producer of composite and specialty polymer resins,has selected Sopheon's Accolade product life cycle management (PLM) solution toenhance the company's product innovation and portfolio management processes.Scott Bader will deploy the Sopheon system among users in research anddevelopment, marketing and executive roles at company locations in the U.K.,France, North America, Croatia, South Africa and Dubai. Founded in 1920, Scott Bader has a rich history as a product innovator. Thecompany created the first polyester resin that would cure at room temperature,the first air-drying polyesters, and the first polyester resins for marineapplications. The latter were used to make the hull for the world's first largeglass-reinforced plastic boat. Scott Bader is a past winner of the QueensAward, the highest honor a U.K. company can receive for technologicalinnovation. Against this backdrop of achievement, Scott Bader recently launched anorganization-wide strategic initiative aimed at renewing the company'scommitment to innovation. A principal goal of the effort is to increase marketshare by accelerating product development and bringing more successful productsto market. Underlying strategies include shifting the focus of research anddevelopment away from custom resin solutions toward new-to-the-world productswith broad market appeal. Sopheon's Accolade system will play a central part inthe initiative by enabling Scott Bader to automate its product developmentprocess and make more informed decisions about which product ideas to develop. In addition to providing process automating capabilities, the Accolade modulesbeing deployed by Scott Bader will furnish advanced support for productportfolio, resource and idea management. Expected advantages include moreeffective prioritization of product development projects, improved visibility ofproject details, stronger collaboration within project teams and acrossfunctional silos, and more consistent focus of resources on commerciallypromising product opportunities. The idea management module will facilitate thesubmission and capture of product ideas and supply scorecards that will helpusers systematically and objectively evaluate them. Scott Bader is alsoimplementing an Accolade Accelerator application that will reduce the amount oftime required to put the company's new innovation process in place. "It's important to our business success that we continue to further the maturityof our innovation process," said Global Research and Development Director RoyPhillipps of Scott Bader. "One area where we want to grow in sophistication isprocess measurement. Accolade will help us capture the metrics needed to trackand evaluate the efficiency and predictability of our process and the businessvalue of the projects that pass through it. The best-practice content providedby the Sopheon system is also important to us because it will enhance ourreporting capabilities and support the kind of 'what-if' analysisrequired to make the right go/kill business decisions on projects coming intoour developmental pipeline. Chemistry is our business. But innovation is ourpath to creating value for our customers. We view Accolade as a criticalcomponent of our value-creation strategy." "Today's chemical industry is $2.2 trillion in size and growing," said BryanSeyfarth, solutions marketing director for Sopheon. "For most chemicalproducers, however, product commoditization is a significant, continuingchallenge. Scott Bader has long understood that the answer is productinnovation. They have made it a focal point of their business goals andphilosophy. The business decision-support and process efficiencies thatAccolade can provide are directly aligned with their requirements. Scott Baderjoins more than 50 top chemical and chemical-related companies around the worldthat are using Accolade today to address their needs for effective innovationprocess governance." Sopheon Accolade(R) is a registered trademark of Sopheon plc. All other trademarks and registered trademarks are the sole property of theirrespective owners. About Scott Bader Scott Bader is a global company which manufactures a wide range of UPR, DCPD andVE resins, compounded resins, gelcoats, bonding pastes and structural adhesivesfor the composite industry. Scott Bader is also a major European distributor ofreinforcements and ancillary products. Scott Bader Composites supplies highquality, technically superior polyester resins and gelcoats under the Crystic(R)brand name from manufacturing locations around the world. For more information,please visit www.scottbader.com. About Sopheon Sopheon (LSE:SPE) is an international provider of software and services thathelp organizations improve the business impact of product innovation. Sopheon'ssolutions automate and govern the innovation process, enabling companies toincrease revenue and profits from new products. Sopheon is listed on the AIMMarket of the London Stock Exchange and on the Euronext in the Netherlands. Formore information, please visit www.sopheon.com. For further information contact: Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 685 735Arif Karimjee, CFO Andrew Tan Hansard Tel : + 44 (0) 207 245 1100 + 44 (0) 7957 203 685Floor van Maaren Citigate First Financial Tel : + 31 (0) 205 754 010 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
6th Sep 20077:00 amPRNHalf-yearly Report
17th Aug 200710:02 amRNSAIM Rule 26
13th Aug 20077:00 amPRNRe Agreement
19th Jul 20077:00 amPRNTrading Update
10th Jul 20077:01 amRNSGlatfelter Partnership
9th Jul 20077:00 amPRNInvestment in Partner
29th Jun 200710:15 amPRNDirectors' Options
29th Jun 20077:00 amRNSTotal Voting Rights
22nd Jun 200712:04 pmPRNAcquisition Update
18th Jun 20072:30 pmBUSChurch & Dwight Chooses Accolade(R) to Enhance Product Innovation and Portfolio Management
18th Jun 20077:00 amPRNContract Win
11th Jun 20072:30 pmBUSSopheon Announces Agreement to Acquire Alignent Software
11th Jun 20077:00 amPRNAGM Statement
11th Jun 20077:00 amPRNAcquisition
22nd May 20077:00 amPRNContract Win
16th May 20072:30 pmBUSSABMiller plc Taps Sopheon to Power Global Innovation Process Initiative
16th May 20078:18 amPRNContract Win
10th May 20077:00 amPRNProduct Launch
2nd May 20077:00 amPRNQ1 Trading Update
20th Apr 200710:23 amRNSDirector/PDMR Shareholding
29th Mar 20077:00 amPRNFinal Results
27th Mar 20072:45 pmBUSWinbond Israel Advances New Product Innovation with Sopheon's Accolade(R)
27th Mar 20077:00 amPRNContract Win
20th Mar 20071:45 pmBUSLand O'Lakes to Deploy Sopheon's Product Life Cycle Management Solution
20th Mar 20077:00 amPRNContract Win
25th Jan 20077:00 amPRNDirector/PDMR Shareholding
24th Jan 20073:57 pmPRNSchedule 10
19th Jan 20077:00 amPRNTrading Update
29th Dec 20067:00 amRNSTotal Voting Rights
20th Oct 20067:01 amRNSMicrosoft Project Server
20th Oct 20067:00 amPRNTrading Update
19th Oct 20067:01 amRNSTop 40 Software Vendor
13th Oct 20062:28 pmPRNOption Exercise
12th Sep 20067:00 amPRNOrangina Contract Win
31st Aug 20067:00 amPRNInterim Results
21st Jul 20067:00 amPRNTrading Update
12th Jul 20067:01 amRNSContract
16th Jun 20067:00 amPRNAGM Statement
14th Jun 20067:00 amPRNTimex Contract Win
12th Jun 20062:30 pmPRNAdditional Listing
10th May 200610:00 amPRNAdditional Listing
3rd May 20067:00 amPRNGrant of Options
19th Apr 20064:30 pmPRNAdditional Listing
19th Apr 20067:00 amPRNElectrolux Contract Win
18th Apr 20067:00 amPRNFinal Results
10th Apr 20067:00 amPRNContract Win
5th Apr 20067:00 amPRNNotice of Results
21st Mar 20067:00 amPRNFrench Joint Venture
2nd Mar 20067:03 amRNSContract Win
31st Jan 20067:02 amRNSIndustry Recognition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.